Astera Labs, Inc. $ALAB Stock Sold by United Capital Management of KS Inc.

United Capital Management of KS Inc. lowered its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 10.6% in the third quarter, HoldingsChannel.com reports. The firm owned 28,413 shares of the company’s stock after selling 3,386 shares during the period. United Capital Management of KS Inc.’s holdings in Astera Labs were worth $10,114,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Amazon Com Inc. acquired a new position in Astera Labs during the second quarter worth $134,172,000. Edgestream Partners L.P. purchased a new position in shares of Astera Labs during the first quarter worth $1,891,000. Sanders Morris Harris LLC acquired a new stake in shares of Astera Labs in the third quarter valued at $4,821,000. Lido Advisors LLC grew its stake in shares of Astera Labs by 123.4% in the first quarter. Lido Advisors LLC now owns 27,477 shares of the company’s stock valued at $3,012,000 after buying an additional 15,180 shares in the last quarter. Finally, Silvant Capital Management LLC acquired a new stake in shares of Astera Labs in the second quarter valued at $11,277,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Shares rallied alongside a broader tech-stock surge, providing a near-term market tailwind after a sharp recent pullback. Astera Labs rallies 14% on tech stock surge
  • Positive Sentiment: Strong business momentum may support investor confidence: third-quarter revenue was about $585 million, and fourth-quarter revenue guidance had a midpoint of $740 million. An analyst upgrade highlighted rising revenue per accelerator as customers adopt higher-value Scorpio switches, alongside opportunities in optical and rack-level solutions. Astera Labs Is Increasing Their Revenue Per Accelerator
  • Neutral Sentiment: The rebound follows a reported 26% five-session decline despite strong earnings and guidance. Competing semiconductor companies also reported robust data-center growth, underscoring strong sector demand but keeping the competitive backdrop in focus. Astera Labs Stock Drops 26% in a Week Despite Strong Earnings
  • Negative Sentiment: Director Stefan Dyckerhoff reported selling shares in two transactions at an average price of $211.41. The sales were made under a pre-arranged Rule 10b5-1 plan, which may temper their significance as a signal of his outlook. SEC Form 4 filing

Astera Labs Stock Up 13.7%

Astera Labs stock opened at $216.87 on Tuesday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a market cap of $37.62 billion, a PE ratio of 86.40 and a beta of 3.85. The company’s 50 day moving average is $299.01 and its two-hundred day moving average is $256.00.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 27.30%. The business had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. During the same quarter in the previous year, the firm posted $0.49 earnings per share. The company’s quarterly revenue was up 153.6% compared to the same quarter last year. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ALAB shares. BMO Capital Markets assumed coverage on Astera Labs in a report on Thursday, November 5th. They issued an “outperform” rating and a $375.00 price objective on the stock. Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday. Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Finally, Royal Bank Of Canada cut their price target on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 4th. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $320.85.

View Our Latest Stock Analysis on Astera Labs

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the completion of the transaction, the director directly owned 1,987 shares of the company’s stock, valued at $420,071.67. The trade was a 81.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 408,558 shares of company stock valued at $126,050,884. 10.40% of the stock is owned by company insiders.

Astera Labs Profile

(Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.